Literature DB >> 1812352

A new macrocyclic MRI contrast agent: Gd MCTA complex.

M Schaefer1, D Meyer, S Beaute, D Doucet.   

Abstract

A new macrocyclic complex Gd-MCTA has been synthesized which exhibits a higher LD 50 compared to Gd-DOTA. These two complexes show comparable NMRD profiles.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1812352     DOI: 10.1002/mrm.1910220215

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  1 in total

1.  Randomised double blind trial of the safety and efficacy of two gadolinium complexes (Gd-DTPA and Gd-DOTA).

Authors:  P Brugières; A Gaston; H R Degryse; P M Parizel; A M de Schepper; I Berry; C Manelfe; F Le Bras; C Marsault; W Wichmann
Journal:  Neuroradiology       Date:  1994       Impact factor: 2.804

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.